Edit |   |
---|---|
Antigenic Specificity | CD20, Human (Ublituximab biosimilar) |
Clone | Ublituximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD20 Recombinant Antibody (Ublituximab). Ublituximab is an immunomodulator. It binds to CD20. It is in Phase 3 clinical trials for multiple sclerosis. It is also in "U2" Phase 3 clinical trials for chronic lymphocytic leukemia in combination with Umbralisib. |
Immunogen | n/a |
Other Names | Anti-CD20 Recombinant Antibody, Research Grade Ublituximab, Anti-Human CD20 Recombinant Antibody(Ublituximab), LFB-R603, TG-1101, TGTX-1101, Antibody Drug Analogues, Monoclonal Antibody, YR1251, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1174014-05-1 |
Catalog # | YR1251 |
Price | please inquire |
Order / More Info | CD20, Human (Ublituximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |